ART-2612

N/A

Report date: 2024/07/22 17:37:08
NME

Base Information

Drug NameART-2612
Drug Alias NameART-2612ART 26.12ART26.12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid binding protein 5 inhibitors
TargetsFatty acid binding protein 5
Therapy Area/IndicationsAnxietyPainPeripheral Nervous System Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStony Brook UniversityThe Research Foundation of the State University of New York
China Registration ClassN/A

Develop Information

Active CompaniesArtelo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAnxietyPainPeripheral Nervous System Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A